Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

VK launched a service for tutors and learners

8/13/24 VKCO

Element will produce equipment for drones

8/13/24 ELMT

Board of Directors of Rostelecom recommended that dividends be paid for 2023

8/13/24 RTKM

Slavneft reported for 6 months of 2024 by RAS

8/13/24 SLAV

Aeroflot's passenger traffic grew by 14.7% in July

8/13/24 AFLT

TMK reported for 6 months of 2024 by IFRS

8/13/24 TRMK

Corporate Center X5 started distribution of shares

8/12/24 X5

Alrosa reported for 6 months of 2024 by RAS

8/12/24 ALRS

Alrosa reported for 6 months of 2024 by IFRS

8/12/24 ALRS

Lukoil was the first in Russia to launch production of technical fluids for electric vehicles

8/12/24 LKOH